Nutriband Inc. Warrant

NTRBW

...

NTRBW: Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Show NTRBW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NTRBW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NTRBW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NTRBW's company Twitter account

WallStreetBets

Number of mentions of NTRBW in WallStreetBets Daily Discussion

NTRBW News

Recent insights relating to NTRBW

CNBC Recommendations

Recent picks made for NTRBW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NTRBW

Corporate Flights

Flights by private jets registered to NTRBW